| 1 |
35321401 | Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer's disease? | 2022 |
2 |
| 2 |
33691599 | The gut microbiota during the progression of atherosclerosis in the perimenopausal period shows specific compositional changes and significant correlations with circulating lipid metabolites. | 2021 Jan-Dec |
1 |
| 3 |
34099706 | Phospholipids of APOE lipoproteins activate microglia in an isoform-specific manner in preclinical models of Alzheimer's disease. | 2021 Jun 7 |
1 |
| 4 |
32949768 | Age-related and atherosclerosis-related erythropathy in ApoE/LDLR-/- mice. | 2020 Dec 1 |
1 |
| 5 |
30576919 | NOXA1-dependent NADPH oxidase regulates redox signaling and phenotype of vascular smooth muscle cell during atherogenesis. | 2019 Feb |
1 |
| 6 |
31246210 | Eicosapentaenoic acid in the form of phospholipids exerts superior anti-atherosclerosis effects to its triglyceride form in ApoE-/- mice. | 2019 Jul 17 |
1 |
| 7 |
28241068 | Liver X receptor agonist treatment significantly affects phenotype and transcriptome of APOE3 and APOE4 Abca1 haplo-deficient mice. | 2017 |
2 |
| 8 |
28333036 | APOE ε4 specific imbalance of arachidonic acid and docosahexaenoic acid in serum phospholipids identifies individuals with preclinical Mild Cognitive Impairment/Alzheimer's Disease. | 2017 Mar 23 |
4 |
| 9 |
28900205 | ApoE4-associated phospholipid dysregulation contributes to development of Tau hyper-phosphorylation after traumatic brain injury. | 2017 Sep 12 |
1 |
| 10 |
26175148 | ABCA1 is Necessary for Bexarotene-Mediated Clearance of Soluble Amyloid Beta from the Hippocampus of APP/PS1 Mice. | 2016 Mar |
1 |
| 11 |
25505264 | LDL receptor and ApoE are involved in the clearance of ApoM-associated sphingosine 1-phosphate. | 2015 Jan 23 |
1 |
| 12 |
23601809 | Effects of a high-fat, high-cholesterol diet on brain lipid profiles in apolipoprotein E ε3 and ε4 knock-in mice. | 2013 Sep |
2 |
| 13 |
20164599 | Profiling brain and plasma lipids in human APOE epsilon2, epsilon3, and epsilon4 knock-in mice using electrospray ionization mass spectrometry. | 2010 |
2 |
| 14 |
20543142 | Diet-induced lipid accumulation in phospholipid transfer protein-deficient mice: its atherogenicity and potential mechanism. | 2010 Oct |
1 |
| 15 |
19472365 | Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E. | 2009 May-Jun |
1 |
| 16 |
19608875 | Oxidized phospholipid species promote in vivo differential cx43 phosphorylation and vascular smooth muscle cell proliferation. | 2009 Aug |
1 |
| 17 |
19956623 | Loss of PDZK1 causes coronary artery occlusion and myocardial infarction in Paigen diet-fed apolipoprotein E deficient mice. | 2009 Dec 1 |
1 |
| 18 |
18667621 | Ceramide is responsible for the failure of compensatory nerve sprouting in apolipoprotein E knock-out mice. | 2008 Jul 30 |
2 |
| 19 |
17038631 | Macrophage phospholipid transfer protein deficiency and ApoE secretion: impact on mouse plasma cholesterol levels and atherosclerosis. | 2007 Jan |
1 |
| 20 |
16254198 | Distinct cellular loci for the ABCA1-dependent and ABCA1-independent lipid efflux mediated by endogenous apolipoprotein E expression. | 2006 Jan |
1 |
| 21 |
15890642 | Engineering conformational destabilization into mouse apolipoprotein E. A model for a unique property of human apolipoprotein E4. | 2005 Jul 15 |
1 |
| 22 |
15364338 | Rapid reversal of endothelial dysfunction in hypercholesterolemic apolipoprotein E-null mice by recombinant apolipoprotein A-I(Milano)-phospholipid complex. | 2004 Sep 15 |
1 |
| 23 |
14504179 | Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E-null mice. | 2003 Oct 7 |
1 |
| 24 |
11719520 | Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice. | 2002 Feb 1 |
1 |
| 25 |
11893773 | ApoE-dependent sterol efflux from macrophages is modulated by scavenger receptor class B type I expression. | 2002 Mar |
1 |
| 26 |
11893784 | Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice. | 2002 Mar |
2 |
| 27 |
11902115 | A new role for apolipoprotein E: modulating transport of polyunsaturated phospholipid molecular species in synaptic plasma membranes. | 2002 Jan |
3 |
| 28 |
12093886 | Increased ABCA1 activity protects against atherosclerosis. | 2002 Jul |
1 |
| 29 |
11742879 | Sterol efflux mediated by endogenous macrophage ApoE expression is independent of ABCA1. | 2001 Dec |
3 |
| 30 |
9884341 | Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. | 1999 Jan |
1 |
| 31 |
10101254 | Antioxidant mechanisms in apolipoprotein E deficient mice prior to and following closed head injury. | 1999 Mar 30 |
1 |
| 32 |
10533050 | Distinct alterations in phospholipid metabolism in brains of apolipoprotein E-deficient mice. | 1999 Nov 15 |
3 |